UNH Beats Est, Ups 2011 Guidance - Analyst Blog
July 19 2011 - 9:00AM
Zacks
UnitedHealth Group Inc. (UNH) reported second quarter 2011
operating earnings of $1.16 per share, beating the Zacks Consensus
Estimate of 93 cents.
Earnings also compared favorably with 99 cents per share
reported in the prior-year quarter. Net earnings increased 13% year
over year to $1.3 billion in the reported quarter. Results were
aided by a strong revenue growth from UnitedHealthcare, as well as
from Optum businesses.
Operational Update
UnitedHealth reported revenue of $25.23 billion in the quarter,
up 8.5% year over year. Results also surpassed the Zacks Consensus
Estimate of $24.96 billion. The revenue upside was led by an 8%
increase in revenues in its health benefits business –
UnitedHealthcare, and a 19% increase in health services business
branded under Optum.
Operating costs increased 108.8% year over year to $3.7 billion.
The medical cost ratio stood at 81.4%, down 10 basis points year
over year.
Segment Update
UnitedHealthcare revenues climbed 8% year over
year to $23.7 billion. The improvement was due to an increase in
the number of members served. Operating earnings improved 13% year
over year to $1.8 billion, with operating margin expanding 30 basis
points (bps) to 7.4%, benefiting from cost containment
measures.
Total commercial members increased 1.11 million year over year
to 25.7 million members. Total medical members increased 1.64
million year over year to 34.18 million members.
OptumHealth revenues surged 55% year over year
to $1.7 billion, driven by an expansion in clinical services and a
strong consumer growth in population health management products
sold to payers and plan sponsors. Operating earnings of $135
million represented a 5% year-over-year decrease. This earnings
decrease was driven by a margin decline of 430 bps to 8.1%, which
reflected costs related to the implementation of Mental Health
Parity legislation, internal business realignments and revisions to
service arrangements, as well as continued investments in new
market development and growth.
OptumInsight reported revenues of $658 million,
up 324% year over year, primarily driven by an organic growth and
contributions from recent acquisitions. Operating earnings
increased a whopping 45% year over year to $87 million. Operating
margin improved by 190 bps to 13.2%, reflecting an increased level
of higher margin product and solution sales.
OptumRx reported revenue growth of 12% year
over year to gross $4.7 billion, driven by a growth in people
served and prescription volumes. Operating earnings decreased 12%
year over year to $118 million. Higher revenues were offset by
costs to support growth initiatives.
Financial Update
UnitedHealth ended the first quarter with cash and short-term
Investments of $12.3 billion, up 9.8% from 2010 end. Long-term debt
increased 8% from the 2010 level to total $9.4 billion at second
quarter end.
Operating cash flows in the quarter under review totaled $2.4
billion, up 26% from 2010 end.
2011 Guidance
UnitedHealth kept its revenue guidance unchanged at $101
billion. The company increased its net earnings guidance to
$4.15–$4.25 per share from the previous forecast of $3.95–$4.05 per
share. Cash flow from operations is estimated to be more than $6.0
billion.
Dividend Update
On June 21, 2011, UnitedHealth Group paid a cash dividend of
16.25 cents per share. This represented an increase over the
quarterly dividend of 12.50 cents per share that the company had
paid at the beginning of second quarter 2010. The company’s
annualized 10-year dividend growth rate was 52.2%.
A Quick Look at Peers
The company’s close peers Aetna Inc. (AET),
WellPoint Inc. (WLP), Humana Inc.
(HUM) and CIGNA Corp. (CI) are scheduled to
release their second quarter 2011 earnings within a fortnight of
UnitedHealth’s earnings release. While WellPoint and Aetna would
report on July 27, followed by Humana on August 1, CIGNA would come
out with its earnings report on August 4.
All of these insurers exceeded the Zacks Consensus Estimate in
the first quarter, owing to their favorable performance. There was
some investors’ skepticism at the start of the year as to how the
companies would fare, with the minimum medical ratio provision
getting affected this year. However, results of the major companies
revealed that the provision did impact their earnings
considerably.
We expect earnings upbeat in this quarter as well from all the
major players owing to low medical utilization, favorable business
performance, easing of the Health Care Act uncertainty, increased
share repurchases and dividend hikes.
Going Forward
We expect UnitedHealth to report earnings beat going forward.
The company’s health benefits business UnitedHealthcare is expected
to grow with its reputable service, value and innovation of
affordable benefit products, combined with balanced and trusted
local market engagements. The unit has recorded increased
memberships even amid a soft employment scenario.
UnitedHealth’s health services, branded under Optum, are also
likely to perform well over the course of this year. Management
intends to expand the health service business to 30–40% of
operating earnings over the longer term, and the company has been
making acquisitions in the area. Currently, health services
generate about 20% of operating earnings. Management thinks that
since the company is under-penetrated in the health service area,
investment in this field will be beneficial over the long term.
AETNA INC-NEW (AET): Free Stock Analysis Report
CIGNA CORP (CI): Free Stock Analysis Report
HUMANA INC NEW (HUM): Free Stock Analysis Report
UNITEDHEALTH GP (UNH): Free Stock Analysis Report
WELLPOINT INC (WLP): Free Stock Analysis Report
Zacks Investment Research
Aetna (NYSE:AET)
Historical Stock Chart
From May 2024 to Jun 2024
Aetna (NYSE:AET)
Historical Stock Chart
From Jun 2023 to Jun 2024